| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Nippon India Nifty Pharma ETF |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.15 |
| Equity |
99.96 |
| Trep |
0.19 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
56.31% |
| Top 10 Holdings |
78.54% |
| Top 25 Holdings |
100.00% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
99.96 |
| Cash |
0.04 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
4.22 |
| PE Ratio |
31.76 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
21.29 |
| DIVI LABORATORIES LTD. |
9.69 |
| Cipla Limited |
9.39 |
| Dr Reddys Laboratories Limited |
9.36 |
| Lupin Limited |
6.58 |
| Torrent Pharmaceuticals Limited |
5.22 |
| Laurus Labs Limited |
4.73 |
| Aurobindo Pharma Limited |
4.26 |
| Alkem Laboratories Limited |
4.19 |
| Glenmark Pharmaceuticals Limited |
3.83 |
| Biocon Limited |
3.30 |
| Mankind Pharma Limited |
3.03 |
| Zydus Lifesciences Limited |
2.79 |
| IPCA Laboratories Limited |
2.58 |
| J B Chemicals and Pharma Ltd |
1.93 |
| Gland Pharma Limited |
1.85 |
| Abbott India Limited |
1.81 |
| Ajanta Pharma Limited |
1.48 |
| Wockhardt Limited |
1.44 |
| Piramal Pharma Limited |
1.21 |
| Triparty Repo |
0.19 |
| Net Current Assets |
-0.15 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|